[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_76":77},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":16,"_18":-5,"_19":-5,"_20":21,"_22":23,"_24":25,"_26":27,"_28":27,"_29":-5,"_30":31,"_32":33,"_34":-5,"_35":36,"_37":38,"_39":-5,"_40":-5,"_41":42,"_43":-5,"_44":-5,"_45":46,"_47":48,"_49":50,"_51":52,"_53":52,"_54":-5,"_55":36,"_56":57},"id","miwo0d1hw2uplj2fyz1i9gjrp","revision",1,"title","6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)","originalTitle","summary","reason","source",{"_11":66,"_67":68,"_69":70,"_71":52,"_72":73,"_74":75},"links",{"_63":64,"_57":65},"publishedAt","2026-10-29T16:21:10.000Z","discoveredAt","2026-10-30T04:45:05.743Z","timelineAt","category","tags",[],"stockSymbols",[62],"score","selected",false,"channel","news","story","x","readingMode","full","author","language","body",{"_58":-5,"_57":59,"_60":-5,"_61":36},"outline",[],"relatedStories",[],"indexable",true,"markdownAvailable","group","hasTranslation","bodyLanguage","original","zh","

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-41316

Alpha Tau Medical Ltd.

(Exact Name of Registrant as Specified in Its\nCharter)

Kiryat HaMada St. 5

Jerusalem, Israel 9777605

+972 (3) 577-4115

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual\nreports under cover of Form 20-F or Form 40-F.

Form 20-F ☒\n Form 40-F ☐

CONTENTS

On October 29, 2026, Alpha Tau Medical Ltd. (the\n“Company”) issued a press release titled “Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of\nthe Tel Aviv Stock Exchange.” A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

EXHIBIT INDEX

\n \n \n \n \n \n \n \n \n

Exhibit No.		Description
99.1		Press release dated October 29, 2026.

SIGNATURES

Pursuant to the requirements of the Securities\nExchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly\nauthorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

	Alpha Tau Medical Ltd.

Date: October 29, 2026	By:	/s/ Uzi Sofer
		Uzi Sofer
		Chief Executive Officer

","zhKind","complete","DRTS","aihot","/items/miwo0d1hw2uplj2fyz1i9gjrp","https://www.sec.gov/Archives/edgar/data/1871321/000121390026113681/0001213900-26-113681-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1794355200&sig=945a152a30c03baf","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1794355200&sig=93f2a630554a1a8e 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1794355200&sig=e637bb06f9c2f92c 96w","changelogVersion","2026-10-01T08:00"]